Senores Pharmaceuticals - Share Price & Details
Circuit Limit
2,895.00/648.20
High price all time
751.0
Broker Recommendations
| Date |
Author |
Type |
Reco Price |
Target Price |
Potential |
Source |
PDF Link |
| 21 Jan 2026 |
Choice Institutional Equities |
Buy |
₹783.15 |
₹1,045 |
25.1% |
moneycontrol |
View |
| 21 Jan 2026 |
Choice Institutional Equities |
Buy |
₹0 |
₹2,800 |
1239.7% |
moneycontrol |
View |
| 07 Nov 2025 |
Choice Equity Broking |
Buy |
₹822.3 |
₹1,010 |
28.1% |
moneycontrol |
View |
Peer Comparison
About Senores Pharmaceuticals
Senores Pharmaceuticals Limited is listed on NSE.
Quarterly Table
| Metrics | Dec 2024 | Mar 2025 | Sep 2025 |
|---|
| Sales | 9.6 | 11.9 | 35.3 |
|---|
| Expenses | 12.0 | 14.6 | 33.8 |
|---|
| Operating Profit | -2.4 | -2.7 | 1.5 |
|---|
| OPM % | -25.11% | -22.93% | 4.3% |
|---|
| Other Income | 7.2 | 9.3 | 11.4 |
|---|
| Interest | 2.7 | 2.4 | 1.6 |
|---|
| Depreciation | 0.8 | 1.3 | 3.7 |
|---|
| Profit before tax | 1.3 | 2.9 | 7.7 |
|---|
| Tax % | -18.6% | -27.6% | 15.9% |
|---|
| Net Profit | 1.1 | 2.0 | 6.4 |
|---|
| EPS in Rs | 0.32 | 0 | 1.4 |
|---|
| Metrics | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 |
|---|
| Sales | 103.0 | 114.2 | 138.0 | 174.6 |
|---|
| Expenses | 77.3 | 94.8 | 103.8 | 120.6 |
|---|
| Operating Profit | 25.7 | 19.4 | 34.2 | 54.0 |
|---|
| OPM % | 24.93% | 17.02% | 24.76% | 30.93% |
|---|
| Other Income | 5.2 | 11.8 | 3.4 | 3.8 |
|---|
| Interest | 6.2 | 5.3 | 5.0 | 5.3 |
|---|
| Depreciation | 4.2 | 5.2 | 6.0 | 7.9 |
|---|
| Profit before tax | 20.5 | 20.7 | 26.5 | 44.6 |
|---|
| Tax % | 19.8% | -13.1% | 20% | 24.7% |
|---|
| Net Profit | 16.4 | 18.0 | 21.2 | 33.6 |
|---|
| EPS in Rs | 5.04 | 0 | 4.6 | 7.29 |
|---|
Shareholding Distribution
Shareholding Pattern
Compounded Data
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
42% |
| TTM: |
13% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
76% |
| TTM: |
356% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
0% |
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
204% |
| TTM: |
86% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
289% |
| TTM: |
85% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
0% |
